Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Indications and Efficacy: Obesity Treatment: In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%
Early results show it may offer significant benefits for people living with obesity and related health conditions
At a dose (i.e
Prepared vials should remain refrigerated between 2-8C and protected from repeated temperature changes
These results are unprecedented for any pharmaceutical intervention targeting metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD)
Following this diet could have similar benefits as the medications used to treat inflammation but with fewer side effects
US$ 22.03
US$ 24.03
US$ 24.64
US$ 23.30
US$ 28.23
